Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
International Journal of Molecular Sciences|February 21, 2017
Essential Roles of E3 Ubiquitin Ligases in p53 RegulationSanam Sane, Khosrow RezvaniJournal of Cancer|October 31, 2015
Nucleocytoplasmic Translocation of UBXN2A Is Required for Apoptosis during DNA Damage Stresses in Colon Cancer CellsAmmara Abdullah, Sanam Sane, Jessica L Freeling, et al.Oncotarget|July 19, 2015
A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2Ammara Abdullah, Sanam Sane, Kate A Branick, et al.Cell Stress & Chaperones|December 5, 2015
Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapySanam Sane, Ammara Abdullah, Morgan E Nelson, et al.Cancers|February 25, 2023
Enhancing Anti-Tumorigenic Efficacy of Eugenol in Human Colon Cancer Cells Using Enzyme-Responsive NanoparticlesNisitha Wijewantha, Sanam Sane, Morgan Eikanger, et al.Cancers|October 16, 2025
Liver-Specific Nanoparticle-Mediated Delivery and MMP-Triggered Release of Veratridine to Effectively Target Metastatic Colorectal CancerMahadi Hasan, Morgan Eikanger, Sanam Sane, et al.Journal of Cancer|January 26, 2026
Talin1 Mediates Tumor-Nerve Interactions in Prostate and Breast Cancer CellsBor-Jang Hwang, Gloria Polanco, Sanam Sane, et al.Molecular Oncology|August 15, 2018
UBXN2A enhances CHIP-mediated proteasomal degradation of oncoprotein mortalin-2 in cancer cellsSanam Sane, Andre Hafner, Rekha Srinivasan, et al.Research Square|November 6, 2024
Veratridine, a plant-derived alkaloid, suppresses the hyperactive Rictor-mTORC2 pathway: a new targeted therapy for primary and metastatic colorectal cancerMorgan M Eikanger, Sanam Sane, Kate S Schraufnagel, et al.Oncogene|April 10, 2023
UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancerSanam Sane, Rekha Srinivasan, Rashaun A Potts, et al.Pageof 1